Evaluation of Safety of ZyComb® In Patients With Common Cold - ZIP 3000 (XY-005-IM)

Nycomed1,000 enrolled

Overview

The objectives of the study are to obtain knowledge about the safety in use, the patients' general impression of the treatment and the pattern of use of ZyComb® in an over-the-counter (OTC) setting.

Study Type

OBSERVATIONAL

Enrollment

1,000

Conditions

Common Cold

Interventions

xylometazoline hydrochloride and ipratropium bromide (ZyComb)DRUG

Common cold in a real-life OTC setting

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * For inclusion the patient must buy ZyComb® nasal spray with the intention to start using it either the same or the next day.

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.